Renalytix Plc (LON:RENX – Get Free Report) traded down 4.6% during mid-day trading on Tuesday . The stock traded as low as GBX 30 ($0.37) and last traded at GBX 31 ($0.39). 34,497 shares were traded during trading, a decline of 94% from the average session volume of 618,802 shares. The stock had previously closed at GBX 32.50 ($0.40).
Renalytix Price Performance
The company has a market cap of £37.18 million, a price-to-earnings ratio of -86.11 and a beta of 1.92. The company has a 50-day simple moving average of GBX 32.04 and a 200-day simple moving average of GBX 28.22. The company has a debt-to-equity ratio of 173.95, a quick ratio of 2.42 and a current ratio of 0.59.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Featured Stories
- Five stocks we like better than Renalytix
- What is the S&P/TSX Index?
- Silicon Motion Proves That AI in Motion Stays in Motion
- What is the Nikkei 225 index?
- Undervalued UnitedHealth Group Won’t Be For Long
- Stock Sentiment Analysis: How it Works
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
